The EU grants CELLINK and consortium partner SEK 10 million in project funding. CELLINK’s share amounts to SEK 5 million.

MON, JAN 28, 2019 16:40 CET

CELLINK, together with Academisch Centrum Tandheelkunde Amsterdam (ACTA), has been awarded funding for the project Functionalized Collagen-based Bioink for 3D Bioprinting –”FUNC.”

The project will run for three years with a total budget of 19,5 MSEK. The project is financed to 50 percent through Eurostars. The consortium will develop a ready-to-use biofunctionalized collagen-based ink for 3D bioprinting. FUNC-BIOINK will provide mammalian (human) cells with an optimized biomimetic milieu. The incorporated peptides promote cell attachment, spreading and survival and direct differentiation. FUNC-BIOINK can be used to create a wide array of tissues. Due to its versatility and unmatched quality, FUNC-BIOINK is of interest to academia as well as cosmetic and pharmaceutical industries.

More News